Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3009224	ts-egfrish	— (—)	163	172	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Epilepsy

100

66.88

182.30

1.1

1.0

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

159

+∞

167.33

1.1

0.0

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

158

+∞

167.09

1.1

0.0

—

Malignant neoplasm of eye, brain and central nervous system

152

+∞

161.20

1.1

0.0

—

Malignant neoplasm of brain

151

+∞

161.03

1.1

0.0

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

120

+∞

130.25

1.1

0.0

—

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

+∞

107.91

1.1

0.0

—

Brain glioblastoma

+∞

107.91

1.1

0.0

—

Other medical care

18.97

77.73

1.1

1.0

—

Focal epilepsy

94.16

75.99

1.1

1.0

—

Focal epilepsy, strict definition

92.00

74.01

1.1

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

100.98

72.97

1.1

1.0

—

First line medication for Crohn's disease

15.70

71.25

1.1

1.0

—

Convulsions, not elsewhere classified

18.39

48.43

1.1

1.0

—

Episodal and paroxysmal disorders

8.55

41.17

1.0

—

Persons encountering health services for specific procedures and health care

5.96

34.80

1.1

1.0

—

Neurological diseases

7.72

23.49

1.0

—

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

+∞

22.48

1.0

0.0

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

+∞

17.71

1.1

0.0

—

General symptoms and signs

4.01

15.85

1.1

1.0

—

Any reimbursement code in KELA

21.72

14.75

1.0

—

Intracranial trauma

6.76

10.83

1.0

—

Care involving use of rehabilitation procedures

4.22

10.75

1.1

1.0

—

Stroke, excluding SAH

3.83

10.36

1.1

1.0

—

Stroke, including SAH

3.70

10.18

1.1

1.0

—

Nontraumatic intracranial haemmorrhage

7.79

10.13

1.1

1.0

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

+∞

9.87

1.1

0.0

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

+∞

9.86

1.1

0.0

—

Cerebrovascular diseases (FINNGEN)

4.18

9.69

1.1

1.0

—

Intracerebral haemorrhage

16.29

8.54

1.2

1.0

—

Oxycodone

4.32

8.38

1.1

1.0

—

Malaise and fatigue

4.17

8.03

1.1

1.0

—

Cerebrovascular diseases

3.12

7.93

1.1

1.0

—

Neurological diseases, wide definition

9.49

7.42

1.0

—

STROKE

3.16

7.32

1.1

1.0

—

DVT of lower extremities and pulmonary embolism

3.84

6.93

1.0

—

Delirium, not induced by alcohol and other psychoactive substances

14.29

6.38

1.0

—

Benign neoplasm of brain and other parts of central nervous system

+∞

6.25

1.0

0.0

—

Benign neoplasm of meninges

+∞

6.25

1.2

0.0

—

Headache

3.18

6.08

1.2

1.0

—

Hard cardiovascular diseases

2.65

5.70

1.2

1.0

—

Concussion

5.19

5.69

1.0

—

Visual field defects

12.89

5.58

1.1

1.0

—

Venous thromboembolism

3.05

5.43

1.0

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

+∞

5.22

1.0

0.0

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

+∞

5.21

1.0

0.0

—

Benign lipomatous neoplasm

+∞

5.21

1.0

0.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

+∞

5.21

1.0

0.0

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

+∞

5.14

1.0

0.0

—

Ischaemic Stroke, excluding all haemorrhages

2.88

5.07

1.0

—

Fever of other and unknown origin

2.93

4.15

1.1

1.0

—

Hypothyroidism (congenital or acquired)

+∞

4.15

1.6

0.0

—

Purpura and other haemorrhagic conditions

8.01

4.06

1.0

—

Speech therapy

3.80

1.0

—

Benign neoplasm of brain and other parts of central nervous system

12.02

3.76

1.0

—

Bleeding

2.22

3.70

1.1

1.0

—

5.63

3.65

1.1

1.0

—

Pulmonary embolism

3.24

3.33

1.0

1.1

—

Pulmonary heart disease

3.24

3.33

1.0

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

3.24

3.33

1.0

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

4.50

3.11

1.0

—

Gonarthrosis [arthrosis of knee](FG)

110

0.27

3.10

1.2

1.1

—

Artrosis, including avohilmo

126

0.35

2.94

1.1

—

Arthrosis

106

0.31

2.81

1.2

1.1

—

DVT of lower extremities

3.92

2.77

1.0

—

Hydrocephalus

8.34

2.75

1.0

—

Inflammatory diseases of the central nervous system

8.34

2.75

1.0

—

Benign neoplasm of meninges

6.01

2.70

1.2

1.0

—

Cerebral palsy and other paralytic syndromes

6.01

2.69

1.0

—

Other and unspecified effects of external causes

3.13

2.64

1.0

—

Renal failure

0.00

2.61

0.0

1.0

—

Use of hypnotics and sedatives

116

1.79

2.56

1.1

1.0

—

Elevated blood glucose level

7.15

2.55

1.0

—

Abnormal findings on diagnostic imaging of other body structures

5.46

2.54

1.0

—

Disturbances of skin sensation

2.94

2.41

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

116

1.81

2.32

1.0

—

Fitting and adjustment of other devices

3.54

2.28

1.0

—

Autoimmune diseases related-to ILD

152

0.35

2.28

1.0

1.1

—

Gonarthrosis,primary

108

0.35

2.22

1.2

1.0

—

Herpesviral [herpes simplex] infections

5.56

2.21

1.0

—

Syncope and collapse

2.53

2.18

1.0

—

Abnormal involuntary movements

4.29

2.15

1.0

—

Benzodiazepine use

127

1.74

2.12

1.0

—

Visual disturbances

2.21

2.10

1.1

1.0

—

Symptoms and signs involving speech and voice

2.70

2.10

1.1

1.0

—

Ischemic heart diseases

103

0.36

2.09

1.7

1.0

—

Polyarthropathies

110

0.36

2.08

1.0

1.1

—

Visual disturbances and blindness

2.13

2.08

1.1

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

2.06

0.0

1.0

—

Other specified/unspecified arthritis

0.00

2.06

0.0

1.1

—

Exclusions for E4_PCOS_BROAD

3.50

2.05

1.0

—

Other headache syndromes

3.33

1.96

1.0

—

Ischaemic heart disease, wide definition

101

0.37

1.96

1.7

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

106

1.78

1.96

1.0

—

Inflammatory bowel disease treatment related agents

148

0.46

1.95

1.0

1.1

—

Biguanides

125

0.44

1.91

1.0

1.1

—

Obesity related asthma

0.00

1.87

0.0

1.0

—

Finngen Rheumatological endpoints

137

0.46

1.84

1.1

—

Oral corticosteroids

145

0.46

1.83

1.0

1.1

—

Bacterial infection, other or unspecified

2.03

1.83

1.0

—

Cholecystitis

4.17

1.82

1.0

—

L02BA Anti-estrogens

4.17

1.82

1.0

1.1

—

Conjunctivitis (acute, non atopic)

2.56

1.79

1.0

—

Other diseases of hard tissues of teeth

103

0.36

1.78

1.0

1.1

—

Statin medication

0.41

1.75

1.0

—

Heart failure and coronary heart disease

0.00

1.74

0.0

1.0

—

Superficial injury of wrist and hand

2.92

1.72

1.0

—

Complications of procedures, not elsewhere classified

120

1.73

1.71

1.1

1.0

—

Unspecified lump in breast

3.85

1.71

1.0

1.1

—

Deforming dorsopathies

0.00

1.70

0.0

1.0

—

Senile cataract

0.37

1.68

1.0

—

Organic, including symptomatic, mental disorders

2.11

1.68

1.0

—

Dermatitis and eczema

151

0.48

1.68

1.1

—

Other neurological diseases

1.78

1.63

1.1

1.0

—

Misadventures to patients during surgical and medical care

3.57

1.61

1.0

—

Fracture at wrist and hand level

2.14

1.60

1.0

—

Other menopausal disorders

0.00

1.59

0.0

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.00

1.51

0.0

1.0

—

Sleep apnoea, including avohilmo

134

0.48

1.49

1.0

1.1

—

Certain infectious and parasitic diseases

1.60

1.49

1.0

—

Parodontitis and operation codes

134

0.46

1.48

1.1

—

Other bacterial diseases

116

1.61

1.47

1.0

1.1

—

Other (not insulin) diabetes medications

124

0.49

1.47

1.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

2.00

1.46

1.0

—

Disorders of lens

0.42

1.44

1.0

—

Opioids

1.59

1.42

1.0

—

Angina pectoris

0.40

1.41

1.2

1.0

—

Chronic lower respiratory diseases

145

0.56

1.41

1.1

1.0

—

severe traumatic brain injury, does not include concussion

2.61

1.36

1.0

—

Arthropathies

122

0.54

1.36

1.0

1.1

—

Disorders of conjunctiva

112

1.64

1.36

1.0

—

Unspecific neurodegenerative disorder

0.00

1.36

0.0

1.0

—

Hypo-osmolality and hyponatraemia

2.93

1.35

1.2

1.1

—

Functional dyspepsia

0.00

1.34

0.0

1.1

—

Injuries to the wrist and hand

131

1.55

1.34

1.0

1.1

—

Dental caries 2 and operation codes

118

0.47

1.33

1.0

—

Complications of surgical and medical care, not elsewhere classified

124

1.56

1.33

1.1

1.0

—

Haemorrhoids and perianal venous thrombosis

0.00

1.32

0.0

1.1

—

Type 2 diabetes

125

0.52

1.32

1.0

1.1

—

Coronary atherosclerosis

0.44

1.32

1.3

1.0

—

Chronic kidney disease

0.00

1.32

0.0

1.0

—

Dental operations

0.48

1.32

1.0

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.73

1.28

1.0

—

Type 2 diabetes, strict (exclude DM1)

124

0.53

1.27

1.0

1.1

—

Parasetamol

1.60

1.26

1.0

1.1

—

Conjunctivitis

106

1.64

1.25

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

133

0.55

1.22

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.23

1.20

1.0

1.1

—

Alzheimer disease, including avohilmo

0.00

1.19

0.0

1.0

—

Degenerative diseases of the nervous system

0.00

1.18

0.0

1.0

—

Later onset COPD

0.00

1.18

0.0

1.0

—

Other reaction to severe stress, and adjustment disorders

1.88

1.17

1.0

—

Diabetes medication

138

0.57

1.17

1.0

1.1

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

1.16

0.0

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

1.16

0.0

1.0

—

Operations 2 for CAVS

0.00

1.16

0.0

1.0

—

Calcific aortic valvular stenosis, operated

0.00

1.16

0.0

1.0

—

Calcific aortic valvular stenosis

0.00

1.16

0.0

1.0

—

Ganglion

0.00

1.16

0.0

1.0

—

Excluding asthma or asthma-COPD overlap

101

0.55

1.15

1.0

—

Disorders of eyelid, lacrimal system and orbit

121

0.52

1.15

1.0

—

Diseases of arteries, arterioles and capillaries

0.44

1.15

1.0

—

Polyarthrosis

0.00

1.15

0.0

1.1

—

Chronic periapical parodontitis

2.33

1.12

1.0

—

Voice disturbances

2.33

1.12

1.1

1.0

—

108

1.51

1.11

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

108

1.51

1.11

1.0

—

Complications of medical and surgical care

113

1.60

1.10

1.1

1.0

—

Implicit viral Sepsis

2.38

1.09

1.0

—

Viral Sepsis

2.38

1.09

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

132

1.47

1.09

1.0

1.1

—

All pneumoniae

132

1.46

1.07

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.68

1.07

1.1

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

123

0.58

1.07

1.0

1.1

—

Diseases of oesophagus, stomach and duodenum

141

0.60

1.06

1.0

1.1

—

Transport accidents

1.72

1.06

1.1

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

123

0.61

1.05

1.1

—

Type 2 diabetes, definitions combined

116

0.57

1.05

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

112

0.49

1.05

1.0

—

Nasal polyp

2.12

1.05

1.3

1.0

—

Codeine or tramadol medication

142

0.62

1.05

1.1

1.0

—

Genitourinary diseases

0.55

1.03

1.0

—

Dizziness and giddiness

1.57

1.03

1.0

—

Antenatal screening

0.00

1.02

0.0

1.0

—

Supervision of normal pregnancy

0.00

1.02

0.0

1.0

—

Asthma (only as main-diagnosis), excluding more controls

0.56

1.02

1.1

1.0

—

Sleep apnoea

130

0.57

1.02

1.0

1.1

—

Asthma (only as main-diagnosis)

0.55

1.02

1.1

1.0

—

Nausea and vomiting

2.02

1.01

1.1

—

101

0.45

1.00

1.0

1.1

—

Other joint disorders

122

0.61

1.00

1.1

—

Later onset COPD, excluding more controls

0.00

0.99

0.0

1.0

—

N06DA Anticholinesterases

0.00

0.98

0.0

1.0

—

Use of anticholinesterases

0.00

0.98

0.0

1.0

—

Other noninfective gastroenteritis and colitis

0.00

0.97

0.0

1.0

—

Non-allergic asthma (mode), excluding more controls

0.00

0.97

0.0

1.0

—

Major coronary heart disease event excluding revascularizations

0.50

0.96

1.5

1.0

—

Non-allergic asthma (mode)

0.00

0.96

0.0

1.0

—

Intracranial injury

1.63

0.96

1.0

—

Other pulmonary diagnosis

101

0.59

0.95

1.0

—

Meniscus derangement

101

0.54

0.95

1.1

—

Nerve, nerve root and plexus disorders

141

0.62

0.95

1.0

1.1

—

105

0.51

0.94

1.0

1.1

—

Malignant neoplasm of skin

1.64

0.94

1.1

1.0

—

Enthesopathies of lower limb, excluding foot

1.89

0.94

1.0

—

Other nutritional deficiencies

116

0.51

0.93

1.0

—

Sleep disorders (combined)

138

0.62

0.92

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

121

0.61

0.92

1.1

—

Diverticular disease of intestine

0.53

0.90

1.3

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

0.48

0.90

1.0

—

Major coronary heart disease event

0.52

0.90

1.4

1.0

—

ILD differential diagnosis

0.61

0.89

1.0

—

COPD differential diagnosis

0.61

0.89

1.0

—

Fall on same level

125

1.39

0.89

1.2

1.0

—

Artificial joint operation, meniscal resection

122

0.60

0.89

1.1

—

Alcohol use disorder, Swedish definition

0.47

0.88

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

140

0.58

0.88

1.1

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

122

1.39

0.88

1.1

1.0

—

Parodontitis or operation codes

134

0.60

0.87

1.1

—

Parodontitis

134

0.60

0.87

1.1

—

Abnormalities of breathing

123

0.63

0.86

1.0

1.1

—

Asthma/COPD (KELA code 203)

145

0.63

0.86

1.2

1.0

—

ILD medications

124

1.37

0.85

1.1

1.0

—

Oedema, not elsewhere classified

1.93

0.84

1.0

—

Paracetamol of NSAID medication

0.00

0.83

0.0

1.1

—

Mental and behavioural disorders due to psychoactive substance use

106

0.53

0.83

1.0

1.1

—

Obesity

111

0.54

0.83

1.0

—

Obesity and other hyperalimentation

113

0.53

0.82

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.74

0.82

1.1

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

131

1.39

0.82

1.0

1.1

—

Cellulitis

1.88

0.81

1.2

1.0

—

Pedal cyclist injured in transport accident

1.88

0.81

1.3

1.0

—

Asthma, including avohilmo

146

0.68

0.81

1.1

—

Cholecystectomy

100

1.50

0.80

1.1

1.0

—

Childhood allergy (age < 16)

0.00

0.80

0.0

1.0

—

Presence of other functional implants

0.51

0.80

1.2

1.0

—

Emergency coronary revascularization (for ACS)

0.51

0.80

1.0

—

Heart failure, strict

0.51

0.79

1.0

—

Dental caries 2

120

0.59

0.79

1.0

—

Malignant neoplasm of breast, HER2-negative

1.75

0.79

1.0

1.1

—

Acute renal failure

0.00

0.79

0.0

1.0

—

Valvular operations

0.00

0.79

0.0

1.0

—

Injury of muscle and tendon at lower leg level

0.00

0.79

0.0

1.0

—

Foreign body on external eye

0.00

0.79

0.0

1.0

—

Glomerular diseases

0.00

0.79

0.0

1.0

—

Asthma and allergy, excluding more controls

0.00

0.79

0.0

1.0

—

Superficial injury of head

0.00

0.78

0.0

1.0

—

Asthma and allergy

0.00

0.78

0.0

1.0

—

Atopic dermatitis

0.50

0.78

1.0

—

Symptoms and signs involving the digestive system and abdomen

113

0.67

0.77

1.0

1.1

—

Influenza and pneumonia

130

1.37

0.76

1.0

1.1

—

Spondylolisthesis/Spondylolysis

0.00

0.76

0.0

1.0

—

Autoimmune diseases

126

0.69

0.74

1.1

—

Other arrhythmias

104

0.59

0.74

1.1

1.0

—

Diseases of the digestive system

1.64

0.74

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.51

0.74

1.1

1.0

—

Diseases of male genital organs

0.61

0.73

1.2

1.0

—

Other diseases of the digestive system

1.84

0.73

1.0

—

Other disorders of veins

1.64

0.73

1.0

1.1

—

Diabetes mellitus

132

0.68

0.73

1.1

—

Malignant neoplasm of breast, HER-positive

1.82

0.73

1.0

1.1

—

Substance abuse, excluding more controls

0.55

0.72

1.0

1.1

—

Substance abuse

105

0.55

0.72

1.0

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

1.78

0.72

1.4

1.0

—

Migraine

1.93

0.70

1.0

—

Other heart diseases, wide

136

0.68

0.70

1.1

—

Diabetes, varying definitions

131

0.68

0.70

1.1

—

Accidents

1.38

0.70

1.0

—

Malignant neoplasm of breast

1.68

0.70

1.0

1.1

—

Dental caries 2, only avohilmo

116

0.61

0.70

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

1.85

0.68

1.0

—

Pure hypercholesterolaemia

1.44

0.68

1.0

—

Anxiety (asthma-related co-morbidities)

0.57

0.68

1.0

1.1

—

Medicines for HER+ breast cancer

1.66

0.68

1.0

1.1

—

Asthma

0.66

0.68

1.1

1.0

—

Dental caries 3 and operation codes

112

0.69

0.68

1.1

—

Spinal stenosis

0.54

0.68

1.0

—

Dental operations, only avohilmo

0.65

0.66

1.0

1.1

—

Mental and behavioural disorders due to alcohol

0.53

0.66

1.0

1.1

—

Chronic periodontitis, including avohilmo

133

0.67

0.65

1.1

—

Selective serotonin reuptake inhibitors

120

0.70

0.65

1.2

1.0

—

Persons encountering health services in circumstances related to reproduction

0.62

0.65

1.1

—

Inguinal hernia

0.61

0.65

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.55

0.65

1.1

1.0

—

Spondylopathies

0.64

0.65

1.0

1.1

—

Osteoporosis

1.77

0.65

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

126

0.70

0.64

1.0

1.1

—

Asthma, excluding more controls

0.67

0.64

1.1

1.0

—

Parodontitis or/and operation codes

0.57

0.64

1.2

1.0

—

Dental caries 3

0.68

0.64

1.1

—

Cervicalgia

1.72

0.64

1.2

1.0

—

Dental caries 3, only avohilmo

0.68

0.63

1.1

—

Single delivery by caesarean section

0.00

0.62

0.0

1.0

—

Hypertension

101

0.67

0.62

1.1

1.0

—

Hypertensive diseases

101

0.67

0.62

1.1

1.0

—

Sensorineural hearing loss

0.65

0.62

1.0

—

Asthma, hospital admission 2, infections

101

0.58

0.62

1.0

—

Asthma-related infections

101

0.58

0.62

1.0

—

Asthma (diagnoses ohter than nonallergic)

141

0.67

0.62

1.0

—

Disorders of other endocrine glands

1.59

0.61

1.0

—

Use of other anti-dementia drugs

0.00

0.61

0.0

1.1

—

Use of memantine

0.00

0.61

0.0

1.1

—

Other disorders of urethra and urinary system

1.43

0.61

1.1

1.0

—

Diabetic retinopathy, strict definition

0.00

0.61

0.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

0.65

0.61

1.0

—

Orchitis and epididymitis

0.00

0.60

0.0

1.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

0.60

0.0

1.0

—

Other condition

0.00

0.60

0.0

1.0

—

Gout, strict definition

0.00

0.60

0.0

1.0

—

Biological medication for rheuma

0.00

0.60

0.0

1.0

—

Generalized anxiety disorder

0.00

0.60

0.0

1.0

—

Bacterial intestinal infections, IBD co-morbidities

0.00

0.60

0.0

1.0

—

Pre-eclampsia or eclampsia

0.00

0.60

0.0

1.1

—

All influenza (not pneumonia)

0.00

0.60

0.0

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

0.59

0.0

1.0

—

Type 2 diabetes, wide definition

107

0.67

0.59

1.0

1.1

—

Falls/tendency to fall

112

1.30

0.59

1.0

—

Unspecified acute lower respiratory infection

0.00

0.59

0.0

1.0

—

Insulin, fast-acting (human)

0.00

0.59

0.0

1.0

—

Acute nasopharyngitis (common cold)

0.00

0.59

0.0

1.0

—

Pregnancy with abortive outcome

0.56

0.59

1.2

1.0

—

Alzheimer disease

0.00

0.59

0.0

1.1

—

All anxiety disorders

0.61

0.58

1.0

—

Medical observation and evaluation for suspected diseases and conditions

0.66

0.58

1.2

1.0

—

Pollen allergy

0.00

0.58

0.0

1.0

—

ILD medications: immunosuppressive drugs

108

0.62

0.58

1.0

—

Other specific joint derangements/joint disorders

117

0.69

0.58

1.1

—

Malignant neoplasm of digestive organs

1.49

0.57

1.0

—

Heart failure,strict

0.55

0.57

1.0

—

Inflammatory diseases of female pelvic organs

0.56

0.57

1.2

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

123

0.72

0.57

1.0

—

Psychiatric diseases

113

1.29

0.56

1.0

1.1

—

Mycoses

1.67

0.56

1.3

1.0

—

Glaucoma

0.57

0.56

1.0

—

Insulin, intermediate and long-acting

0.55

1.0

—

Conductive and sensorineural hearing loss

103

0.67

0.54

1.0

—

GI-bleeding

1.58

0.54

1.0

—

Bacterial pneumonia (organism specified)

1.50

0.54

1.0

—

Bacterial pneumonia, not elsewhere classified

1.53

0.53

1.0

—

Myocardial infarction

0.60

0.53

1.5

1.0

—

Viral infections characterized by skin and mucous membrane lesions

1.43

0.52

1.0

—

Implicit bacterial Sepsis

1.42

0.52

1.0

—

Disorders of synovium and tendon

0.60

0.52

1.0

—

Second line medication for Crohn's disease

0.62

0.52

1.0

—

Fracture of lower leg, including ankle

0.62

0.52

1.0

—

Acute sinusitis

0.60

0.52

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

0.68

0.50

1.0

—

Dental caries 2 and operation codes, only avohilmo

0.62

0.49

1.0

—

Renal tubulo-interstitial diseases

120

0.70

0.49

1.0

—

Triptan medication for migraine, single purchase ok

106

0.70

0.49

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

106

0.70

0.49

1.0

—

Asthma (mode)

0.72

0.49

1.1

1.0

—

Diseases of the ear and mastoid process

137

0.78

0.49

1.0

1.1

—

Diseases of the respiratory system

0.69

0.48

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.52

0.48

1.3

1.0

—

Other diseases of urinary system

106

1.27

0.47

1.0

—

Diseases of pulp and periapical tissues

1.47

0.47

1.0

—

Bacterial pneumoniae

1.48

0.46

1.0

—

Urticaria and erythema

1.46

0.46

1.1

1.0

—

Rotator cuff syndrome

0.67

0.46

1.0

—

Dyspnoea

127

0.72

0.46

1.0

—

Other cataract

0.60

0.46

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

128

0.74

0.46

1.1

1.0

—

Pain (limb, back, neck, head abdominally)

1.33

0.45

1.0

—

Hernia

127

0.75

0.44

1.0

1.1

—

Used for control exclusion in common control thyroid runs

118

0.77

0.44

1.2

1.0

—

Other disorders of ear

117

0.74

0.44

1.0

—

Triptan medication for migraine, min. 3 purchases

0.63

0.42

1.0

—

Injuries to the shoulder and upper arm

124

1.28

0.42

1.2

1.0

—

Spondylosis

0.64

0.42

1.0

—

Injuries to the head

137

1.24

0.42

1.0

1.1

—

Disorders of sclera, cornea, iris and ciliary body

0.65

0.42

1.0

—

L04AX Other immunosuppressants

0.64

0.42

1.0

—

Other diseases of intestines

134

0.78

0.42

1.1

—

Dental caries 1 and operation codes

107

0.77

0.42

1.1

—

Diabetic nephropathy, excluding more controls

0.00

0.41

0.0

1.1

—

Alzheimer’s disease (Late onset)

0.00

0.41

0.0

1.1

—

Other external causes of accidental injury

1.27

0.41

1.0

—

Alzheimer’s disease, wide definition

0.00

0.41

0.0

1.1

—

Congenital malformations of heart and great arteries

0.00

0.41

0.0

1.0

—

Subjective visual disturbances

1.52

0.41

1.0

—

Reactive arthropathies

0.00

0.41

0.0

1.0

—

Phobic anxiety disorders

0.00

0.41

0.0

1.0

—

Noninfectious colitis NAS

0.00

0.41

0.0

1.0

—

Thoracic aortic aneurysm

0.00

0.41

0.0

1.0

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.41

0.0

1.0

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.41

0.0

1.0

—

Methotrexate

0.00

0.41

0.0

1.1

—

D07AA Corticosteroids, weak (group I)

0.00

0.41

0.0

1.0

—

Other antidepressants

120

0.78

0.41

1.0

—

Hypertensive diseases (excluding secondary)

0.67

0.41

1.0

—

Polycystic ovarian syndrome, consortium definition

0.66

0.40

1.0

1.1

—

Flat foot [pes planus] (acquired)

0.00

0.40

0.0

1.1

—

Follow-up examination after treatment for malignant neoplasms

0.00

0.40

0.0

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.40

0.0

1.0

—

Missing teeth due to accident, extraction or parodontitis

0.00

0.40

0.0

1.0

—

Nephropathy related operations

0.00

0.40

0.0

1.0

—

Dialysis, with operation codes

0.00

0.40

0.0

1.0

—

Cardiomyopathies, Primary/intrinsic

0.00

0.40

0.0

1.0

—

Tumor necrosis factor alpha inhibitors

0.00

0.40

0.0

1.0

—

Panic disorder

0.00

0.40

0.0

1.0

—

TMD related operations

0.00

0.40

0.0

1.0

—

Enlarged lymph nodes

0.00

0.40

0.0

1.0

—

Congenital malformations of the circulatory system

0.00

0.40

0.0

1.0

—

Abnormal spermatozoa

0.00

0.40

0.0

1.0

—

Acute and transient psychotic disorders

0.00

0.40

0.0

1.0

—

Cardiomyopathy (excluding other)

0.00

0.40

0.0

1.0

—

Trigger finger

0.00

0.40

0.0

1.0

—

Temporomandibular joint disorders

0.00

0.40

0.0

1.0

—

Pre-eclampsia

0.00

0.40

0.0

1.1

—

Direct fill therapy

0.00

0.40

0.0

1.0

—

Depression

134

0.77

0.40

1.0

1.1

—

Codeine

0.75

0.39

1.0

—

Seronegative rheumatoid arthritis

0.00

0.39

0.0

1.1

—

Crohn disease

0.00

0.39

0.0

1.0

—

Other bacterial intestinal infections

0.00

0.39

0.0

1.0

—

L02BG Aromatase inhibitors

1.39

0.38

1.0

1.1

—

Irritable bowel syndrome

1.39

0.38

1.0

1.1

—

Carpal tunnel syndrome

102

0.71

0.37

1.0

—

Presence of cardiac and vascular implants and grafts

0.63

0.36

1.0

—

Open wound of wrist and hand

0.66

0.35

1.0

—

Acute appendicitis

127

1.26

0.35

1.0

1.1

—

Asthma-related pneumonia

1.36

0.34

1.0

—

Asthma-related pneumonia or sepsis

1.36

0.34

1.0

—

Asthma, hospital admissions 3, pneumonia

1.36

0.34

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

115

1.26

0.33

1.1

—

Internal derangement of knee

0.68

0.33

1.0

—

Persons encountering health services in other circumstances, wide

127

1.18

0.32

1.1

1.0

—

Allergic conjunctivitis

1.31

0.32

1.0

—

Dental pulpitis 2

0.77

0.32

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

118

1.21

0.32

1.0

1.1

—

Examination and observation for other reasons

1.26

0.32

1.1

1.0

—

Basal cell carcinoma

1.33

0.31

1.1

1.0

—

Heart failure, not strict

0.76

0.31

1.0

—

Acute appendicitis, no complications

110

1.27

0.31

1.0

—

Pneumonia, organism unspecified

126

1.21

0.30

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

121

0.83

0.30

1.1

1.0

—

Acute bronchitis

1.27

0.30

1.1

1.0

—

Dental pulpitis 2, only avohilmo

0.79

0.29

1.0

1.1

—

Other/unspecified dorsalgia

1.22

0.28

1.1

1.0

—

Other diseases of upper respiratory tract

125

0.83

0.28

1.1

1.0

—

Cardiovascular diseases

0.74

0.28

1.0

—

Other and unspecified disorders of vitreous body

1.28

0.28

1.0

—

Exposure to other specified factors

131

0.79

0.27

1.1

—

Disorders of breast

1.24

0.27

1.0

1.1

—

Injuries to the ankle and foot

117

0.78

0.27

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

113

1.23

0.27

1.1

—

Other functional intestinal disorders

0.70

0.26

1.0

—

Mouth breathing

0.67

0.26

1.0

—

Hernia of abdominal wall

0.67

0.25

1.0

—

Hypertension, essential

0.81

0.25

1.1

—

Unspecified fall

1.22

0.25

1.0

—

Basal cell carcinoma, including avohilmo

1.27

0.24

1.1

1.0

—

Bacterial Sepsis

1.18

0.24

1.0

—

Appendicitis, broad definition

130

1.20

0.24

1.0

1.1

—

124

0.85

0.24

1.1

1.0

—

Metabolic disorders

111

1.18

0.24

1.2

1.0

—

Other abnormal uterine and vaginal bleeding

1.32

0.23

1.0

1.1

—

Diseases of appendix

130

1.19

0.23

1.0

1.1

—

Chronic gastritis

1.32

0.23

1.0

1.1

—

Other heart diseases

0.75

0.23

1.1

1.0

—

Mood disorders, excluding more controls

116

0.84

0.23

1.1

—

Intestinal stricture

1.28

0.23

1.0

1.1

—

Fall on same level involving ice and snow

0.77

0.22

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

136

0.84

0.22

1.0

—

Other intervertebral disc disorders

103

0.83

0.22

1.0

1.1

—

Infections, IBD-co-morbidities

0.00

0.22

0.0

1.0

—

Other degenerative diseases of the nervous system

0.00

0.22

0.0

1.0

—

Otitis media, unspecified

0.00

0.21

0.0

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.19

0.21

1.4

1.0

—

Diabetic neuropathy

0.00

0.21

0.0

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

1.18

0.21

1.1

1.0

—

Myocarditis

0.00

0.21

0.0

1.0

—

Alcohol withdrawal state with delirium

0.00

0.21

0.0

1.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

1.0

—

Foreign body entering into or through eye or natural orifice

0.00

0.21

0.0

1.0

—

Multiple delivery

0.00

0.21

0.0

1.1

—

Ulcerative rectosigmoiditis

0.00

0.21

0.0

1.0

—

Vestibular neuronitis

0.00

0.21

0.0

1.0

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.21

0.0

1.0

—

Stenosis and insufficiency of lacrimal passages

0.00

0.21

0.0

1.0

—

Disorders of continuity of bone

0.00

0.21

0.0

1.0

—

Female infertility, associated with anovulation

0.00

0.21

0.0

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.21

0.0

1.0

—

Glaucoma, exfoliation

0.00

0.21

0.0

1.0

—

Social phobias

0.00

0.21

0.0

1.0

—

Lichen sclerosus et atrophicus

0.00

0.21

0.0

1.0

—

Other benign neoplasms of connective and other soft tissue

0.00

0.21

0.0

1.0

—

Other local infections of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Parodontitis, under 40 years and operation codes

0.00

0.21

0.0

1.0

—

Parodontitis, operation under 40 years and operation codes

0.00

0.21

0.0

1.0

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.21

0.0

1.0

—

Parodontitis, under 40 years

0.00

0.21

0.0

1.0

—

Parodontitis, under 40 years, or operation codes

0.00

0.21

0.0

1.0

—

Hydronephrosis

0.00

0.21

0.0

1.0

—

Rosacea

0.00

0.21

0.0

1.0

—

Thyroiditis, ILD-related definition

0.00

0.21

0.0

1.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

0.21

0.0

1.0

—

Other disorders of breast

0.00

0.21

0.0

1.1

—

Other metabolic disorders

0.00

0.21

0.0

1.0

—

Allergic contact dermatitis

0.00

0.21

0.0

1.0

—

Deposits [accretions] on teeth

0.00

0.21

0.0

1.0

—

Use of donepezil

0.00

0.21

0.0

1.0

—

Pain in throat and chest

122

0.85

0.21

1.1

—

Injury of muscle and tendon at hip and thigh level

0.00

0.21

0.0

1.0

—

Alcoholic liver disease

0.00

0.21

0.0

1.0

—

Glomerulonephritis

0.00

0.21

0.0

1.0

—

Ptosis of eyelid

0.00

0.21

0.0

1.0

—

Transplanted organ and tissue status

0.00

0.21

0.0

1.0

—

Restless leg syndrome

0.00

0.21

0.0

1.0

—

Special screening examination for other diseases and disorders

0.00

0.21

0.0

1.0

—

Lichen planus

0.00

0.21

0.0

1.1

—

Secondary uncertain malignant neoplasm

0.00

0.21

0.0

1.0

—

Atrophic disorders of skin

0.00

0.21

0.0

1.1

—

Inflammatory disease of uterus

0.00

0.21

0.0

1.0

—

Peripheral artery operations in Hilmo

0.00

0.21

0.0

1.0

—

Tooth eruption problems

0.00

0.21

0.0

1.0

—

Disturbance of activity and attention

0.00

0.21

0.0

1.0

—

Diabetic nephropathy

0.00

0.21

0.0

1.1

—

Dementia in Alzheimer disease

0.00

0.21

0.0

1.0

—

Antihypertensive medication - note that there are other indications

0.82

0.21

1.0

—

Benign lipomatous neoplasm

1.16

0.21

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

103

0.76

0.21

1.1

1.0

—

Aortic valve malfunction, age under 60 years

0.00

0.21

0.0

1.0

—

Sequelae of injuries of upper limb

0.00

0.21

0.0

1.0

—

Glomerular disorders in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

L04AD Calcineurin inhibitors

0.00

0.21

0.0

1.0

—

Emotionally unstable personality disorder

0.00

0.21

0.0

1.0

—

Symptoms and signs involving the urinary system

104

0.82

0.21

1.0

—

Cystitis

1.18

0.20

1.0

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.20

0.0

1.0

—

Chalazion

0.00

0.20

0.0

1.0

—

Other disorders of kidney and ureter

0.00

0.20

0.0

1.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.20

0.0

1.0

—

Disorder of lipoprotein metabolism, unspecified

0.00

0.20

0.0

1.0

—

Preparation and fitting of bite rail to mouth

0.00

0.20

0.0

1.0

—

Prolonged pregnancy

0.00

0.20

0.0

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

114

1.16

0.20

1.2

1.0

—

Dermatitis

113

0.80

0.20

1.1

1.0

—

Mood disorders

137

0.86

0.20

1.1

—

Oxicams

1.18

0.19

1.0

1.2

—

Mood [affective] disorders

137

0.86

0.19

1.1

—

Disorders of choroid and retina

105

0.83

0.19

1.0

—

Dorsalgia

109

1.14

0.19

1.1

—

Acute upper respiratory infections

130

0.87

0.18

1.0

—

Polyp of the female genital tract

1.20

0.18

1.0

1.1

—

Persons encountering health services in other circumstances

1.19

0.18

1.0

—

Malignant neoplasm of prostate

0.73

0.17

1.0

—

Other soft tissue disorders, not elsewhere classified

114

1.14

0.17

1.1

—

Hallux valgus (acquired)

0.74

0.17

1.0

1.1

—

Injuries to the knee and lower leg

136

0.88

0.17

1.0

1.1

—

Unspecified haematuria

0.74

0.17

1.0

—

Other disorders of eyelid

0.73

0.17

1.0

—

Neurotic, stress-related and somatoform disorders

125

1.14

0.17

1.0

1.1

—

Other diseases of pleura

0.71

0.17

1.0

—

Implicit Sepsis

100

1.17

0.17

1.0

—

Non-selective monoamine reuptake inhibitors

0.71

0.16

1.0

—

Abnormal findings on examination of blood, without diagnosis

1.17

0.16

1.0

—

Leiomyoma of uterus

1.16

0.16

1.0

1.1

—

Any gastric operation

0.87

0.16

1.0

1.1

—

GASTRO-related operations

0.87

0.16

1.0

1.1

—

Cholelithiasis

104

1.15

0.15

1.1

1.0

—

Endocrine, nutritional and metabolic diseases

0.87

0.15

1.0

—

Gingivitis and periodontal diseases

106

1.12

0.15

1.0

1.1

—

Chronic diseases of tonsils and adenoids

109

0.87

0.15

1.0

—

Other maternal disorders predominantly related to pregnancy

0.79

0.15

1.0

1.1

—

Sciatica+with lumbago

0.80

0.14

1.0

—

Osteopathies and chondropathies

0.80

0.14

1.1

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

102

1.14

0.14

1.1

1.0

—

Diseases of middle ear and mastoid

0.82

0.14

1.0

—

Soft tissue disorders

116

0.90

0.13

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.18

0.13

1.0

—

Shoulder lesions

0.87

0.13

1.0

1.1

—

Anxiety disorders

127

1.12

0.13

1.0

1.1

—

Pain in limb

109

1.13

0.13

1.1

1.0

—

Insulin medication

0.83

0.13

1.0

—

Other retinal disorders

0.81

0.13

1.0

—

Dental caries 1

0.89

0.12

1.1

—

Dental caries, including avohilmo

0.89

0.12

1.1

—

Dental caries 1, only avohilmo

0.89

0.12

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

126

0.90

0.12

1.1

1.0

—

Cholelithiasis, broad definition with cholecystitis

104

1.12

0.12

1.1

1.0

—

Disorders of the thyroid gland

117

0.89

0.11

1.3

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

123

1.13

0.11

1.1

1.0

—

Infections of the skin and subcutaneous tissue

105

1.14

0.10

1.2

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.13

0.10

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.14

0.10

1.0

—

Injuries to the elbow and forearm

113

1.12

0.10

1.0

—

Impingement syndrome of shoulder

1.11

0.09

1.0

—

Exposure to unspecified factor

142

1.09

0.09

1.0

1.1

—

Infections with a predominantly sexual mode of transmission

1.09

0.09

1.4

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.11

0.09

1.0

—

Fracture of shoulder and upper arm

1.11

0.09

1.3

1.0

—

Striking against or struck by other objects

1.09

0.08

1.0

—

Hypothyroidism, strict autoimmune

1.10

0.08

1.1

1.0

—

Persons encountering health services for examination and investigation

0.90

0.08

1.0

—

Spontaneous abortion

0.81

0.08

1.2

1.0

—

Other dorsopathies, not elsewhere classified

109

0.92

0.08

1.1

—

Keratitis

0.83

0.08

1.0

—

Insulin, fast-acting or short human

0.82

0.08

1.0

—

Insulin, fast-acting

0.81

0.08

1.0

—

Hyperlipidaemia, other/unspecified

0.79

0.08

1.2

1.0

—

Haemorrhage from respiratory passages

1.10

0.08

1.0

—

Degeneration of macula and posterior pole

1.07

0.08

1.0

—

Cervical disc disorders

1.06

0.08

1.0

—

Atrial fibrillation and flutter

0.82

0.08

1.2

1.0

—

Injuries to the thorax

1.03

0.07

1.0

—

Glucosamine medication

0.83

0.07

1.0

1.1

—

Transient ischemic attack

1.05

0.07

1.1

1.0

—

Disorders of vitreous body

1.06

0.07

1.0

—

Disorders of vitreous body and globe

1.05

0.07

1.0

—

Other acute lower respiratory infections

0.86

0.07

1.1

1.0

—

Dental pulpitis 4, only avohilmo

123

0.93

0.07

1.0

1.1

—

Dental pulpitis 1, only avohilmo

123

0.93

0.07

1.0

1.1

—

Other and unspecified dermatitis

0.82

0.07

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.08

0.07

1.0

—

Erysipelas

1.07

0.07

1.0

—

Complications of labour and delivery

0.84

0.07

1.1

1.0

—

Tonsillectomy and adenotomy

0.84

0.07

1.0

—

Varicose veins

0.88

0.06

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

0.89

0.06

1.0

—

COPD/asthma/ILD related infections

108

1.07

0.06

1.0

—

COPD/asthma related infections

108

1.07

0.06

1.0

—

Depression or dysthymia

1.09

0.06

1.2

1.1

—

Gastrointestinal diseases

1.08

0.05

1.0

1.1

—

Hypothyroidism, other/unspecified

111

1.07

0.05

1.2

1.0

—

Intestinal infectious diseases

141

0.94

0.05

1.1

—

Diseases of the eye and adnexa

0.94

0.04

1.0

1.1

—

Anxiety disorders, excluding more controls

112

1.07

0.04

1.0

1.1

—

Asthma, unspecified (mode)

0.91

0.04

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.10

0.04

1.1

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

105

1.07

0.04

1.1

1.0

—

Cardiac arrhythmias

0.92

0.04

1.2

1.0

—

Gastro-oesophageal reflux disease

114

0.93

0.03

1.0

—

Any mental disorder

120

1.04

0.03

1.0

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.09

0.03

1.0

—

Asthma, unspecified (mode), excluding more controls

0.92

0.03

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.06

0.02

1.0

—

External causes of morbidity and mortality

1.06

0.02

1.0

—

Dental pulpitis 4

118

0.97

0.01

1.0

1.1

—

Dental pulpitis 1

118

0.97

0.01

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

0.98

0.00

1.1

1.0

—

Appendectomy

119

0.97

0.00

1.0

1.1

—

Constipation

114

1.00

0.00

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

117

0.98

0.00

1.0

1.1

—

Benign neoplasms

109

1.02

0.00

1.2

1.0

—

Bronchitis

136

1.01

0.00

1.1

1.0

—

Low back pain

107

1.01

0.00

1.0

1.1

—

Tramadol

0.96

0.00

1.0

—

Lower back pain or/and sciatica

139

1.00

0.00

1.0

1.1

—

Lumbar disc prolapse

0.98

0.00

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

119

0.97

0.00

1.1

1.0

—

Pain in joint

0.99

0.00

1.0

—

Injury, poisoning and certain other consequences of external causes

0.98

0.00

1.0

—

Dorsopathies

110

0.97

0.00

1.0

1.1

—

Acute tubulo-interstitial nephritis

1.05

0.00

1.0

—

Diseases of oral cavity, salivary glands and jaws

106

1.02

0.00

1.0

1.1

—

Abdominal and pelvic pain

113

0.98

0.00

1.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

0.0

1.0

—

Reactive arthropathies, FINNGEN

0.00

0.0

1.0

—

Bronchiectasis

0.00

0.0

1.0

—

Benign neoplasm: Transverse colon

0.00

0.0

1.0

—

Chronic suppurative otitis media

0.00

0.0

1.0

—

Ovarian dysfunction

0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.0

1.0

—

Vitamin B12 deficiency anaemia

0.00

0.0

1.0

—

Lesion of plantar nerve

0.00

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

0.0

1.0

—

Fibrosis and cirrhosis of liver

0.00

0.0

1.0

—

Disorders of mineral metabolism

0.00

0.0

1.0

—

Atypical facial pain

0.00

0.0

1.0

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

0.0

1.0

—

Other and unspecified injuries of lower leg

0.00

0.0

1.0

—

Unspecified kidney failure

0.00

0.0

1.0

—

Other and unspecified mood [affective] disorders

0.00

0.0

1.0

—

Mixed and other personality disorders

0.00

0.0

1.0

—

Diaphragmatic hernia

0.89

0.00

1.0

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

0.0

1.0

—

Amputation

0.00

0.0

1.0

—

Haemangioma, any site

0.00

0.0

1.0

—

Ulcer of oesophagus

0.00

0.0

1.0

—

Adalimumab

0.00

0.0

1.0

—

Foreign body or object entering through skin

0.00

0.0

1.0

—

Cerebral aneurysm, nonruptured

0.00

0.0

1.0

—

Benign neoplasm of bone and articular cartilage

0.00

0.0

1.0

—

Crohn's disease of small intestine

0.00

0.0

1.0

—

Explicit bacterial Sepsis

0.00

0.0

1.0

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

1.0

—

Retinal detachments and breaks

0.98

0.00

1.0

—

Deep bite

0.00

0.0

1.0

—

Chronic sinusitis

0.95

0.00

1.1

1.0

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

0.0

1.0

—

Provisional assignment of new diseases of uncertain etiology

0.88

0.00

1.2

1.0

—

Other symptoms and signs involving the urinary system

0.00

0.0

1.0

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.0

—

Collagenous colitis

0.00

0.0

1.0

—

Other or ill-defined heart diseases

0.00

0.0

1.0

—

Malignant neoplasm of rectum

0.00

0.0

1.0

—

L02BB Anti-androgens

0.00

0.0

1.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

0.0

1.0

—

Medical abortion

0.92

0.00

1.1

1.0

—

Tuberculosis, wide

0.00

0.0

1.0

—

Enterocolitis due to Clostridium difficile

0.00

0.0

1.0

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.00

0.0

1.0

—

Care involving dialysis

0.00

0.0

1.0

—

Examination and encounter for administrative purposes

0.00

0.0

1.0

—

Non-allergic asthma

0.00

0.0

1.0

—

Desensitization to allergens

0.00

0.0

1.0

—

Other specified/unspecified bacterial intestinal infections

0.00

0.0

1.0

—

Weight loss

0.00

0.0

1.0

—

Other infective otitis externa

0.00

0.0

1.0

—

Contact with other sharp object(s)

0.00

0.0

1.0

—

Contraceptive management

1.00

0.00

1.1

1.0

—

Multiple gestation

0.00

0.0

1.0

—

Prepatellar bursitis

0.00

0.0

1.0

—

Asthma mixed form (mode)

0.00

0.0

1.0

—

Viral warts

0.00

0.0

1.0

—

0.00

0.0

1.0

—

Alcohol-induced chronic pancreatitis

0.00

0.0

1.0

—

0.00

0.0

1.0

—

Rubella [German measles]

0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS